Find a plain language summary of a real-world study evaluating the outcomes of a CDK4/6 inhibitor + aromatase inhibitor (AI) vs. AI alone for patients aged ≥ 75 years with HR+/HER2- metastatic #BreastCancer in routine clinical practice in the U.S. bit.ly/4amSyqG
0
0
0
486
0
Download Image